Overview
- 4 inspections across 4 sites are on record.
- 4 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2023-08-04.
At a glance
Inspections
4
Sites
4
Observations
4
Career since
May 2023
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Mark A. Stein, Ph.D. | 4 Aug 2023 | Human Drugs | On file |
| Charles J. Davidson, MD | 21 Jul 2023 | Medical Devices & Rad Health | |
| Veronique Sebastian, M.D. | 25 May 2023 | Human Drugs | On file |
| Pfizer Inc. | 5 May 2023 | Human Drugs |
Sites inspected
Mark A. Stein, Ph.D.Seattle, United States1 insp.
Charles J. Davidson, MDChicago, United States1 insp.
Veronique Sebastian, M.D.Oklahoma City, United States1 insp.
Pfizer Inc.San Diego, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Veronica L Bush4 shared
Chelsea W Lamm1 shared
Yuanyuan Li1 shared
Corrine M Carter1 shared
Julian C Hanson1 shared
Sherri N Rohlf1 shared
Full investigator report
Get the verbatim findings behind Veronica Bush's 4 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site